Skip to search formSkip to main contentSkip to account menu

Sumatriptan

Known as: 1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide, Sumatriptán, 3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide 
A sulfonamide triptan with vasoconstrictor activity. Sumatriptan selectively binds to and activates serotonin 5-HT1D receptors in the central nervous… 
National Institutes of Health

Related topics

Related topics

43 relations
0.5 ML Sumatriptan 12 MG/ML Cartridge0.5 ML Sumatriptan 12 MG/ML Cartridge [Imitrex]0.5 ML Sumatriptan 12 MG/ML Jet Injector [Sumavel]0.5 ML Sumatriptan 12 MG/ML Prefilled Syringe

Narrower (10)

AlsumaCP 122288CP 122638GR-43175

Broader (5)

Serotonin 5-HT1 Receptor AgonistsSulfonamidesTriptansVasoconstrictor Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Novel Spectrophotometric Methods for Estimation of Naratriptan in Pharmaceutical Dosage Forms
Naratriptan is a triptan drug. Two simple, sensitive and accurate spectrophotometric methods have been developed for the… 
2012
2012
Medication Overuse Headache from Antimigraine Therapy
Medication overuse headache (MOH) is being recognised more often in headache, neurology and primary care clinics, but is still… 
Review
2008
Review
2008
Frovatriptan for the acute treatment of migraine and prevention of predictable menstrual migraine
Frovatriptan is a 5-HT1B/1D receptor agonist that belongs to the triptan therapeutic class. Relative to other triptans… 
2008
2008
Cluster-like headache secondary to trigeminal meningioma
A 30-year-old man presented with episodic severe left orbital pain associated with ipsilateral lacrimation, rhinorrhea, and… 
2006
2006
Influence of delaying gastric emptying on meal‐related symptoms in healthy subjects
Background  Although delayed gastric emptying is often found in functional dyspepsia, a causal role for delayed emptying in… 
Review
2006
Review
2006
Topiramate Prophylaxis and Response to Triptan Treatment for Acute Migraine
Objective.—To evaluate the effect of topiramate migraine prophylaxis on subject responsiveness to triptans used for acute… 
Review
2003
Review
2003
The patient with medication overuse: clinical management problems
Abstract. Patients with chronic headache arise many problems in clinical management, often strictly related to medication overuse… 
1999
1999
Emerging Oral Triptan Therapies
1997
1997
Comparison of the cardiovascular effects of the novel 5-HT(1B/1D) receptor agonist, SB 209509 (VML251), and sumatriptan in dogs.
The systemic cardiovascular effects of a novel 5-hydroxtryptamine (5-HT)(1B/1D)-receptor agonist were investigated in the… 
1995
1995
Patient preferences for migraine therapy: subcutaneous sumatriptan compared with other medications.
BACKGROUND: This study was conducted to identify, from the patient's perspective, the important attributes of a migraine therapy…